Spyre Therapeutics, Inc. (SYRE)
33.60
+0.63
(+1.91%)
USD |
NASDAQ |
Dec 17, 13:29
Spyre Therapeutics Accounts Payable (Quarterly): 7.457M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | 36.62M |
| NovaBay Pharmaceuticals, Inc. | 0.076M |
| Palatin Technologies, Inc. | 7.406M |
| Theriva Biologics, Inc. | 0.795M |
| Oragenics, Inc. | 2.479M |